Skip to main content

Funded Grants

Filter by:
Clear Filters
Filter by:

736 results found

Prototype NIR Ca2+ indicators into refined tools that can be applied for neuronal activity imaging in model organisms

One of the major challenges facing the BRAIN initiative is the development of technologies that will enable the recording of neural activity throughout the entire volume of a rodent brain.


Grant type
Team grants
Area of Research
Neurotechnology
Competition
BRAIN Initiative
Province
Alberta
Start Date
2015

Identification of novel genes causing intracranial aneurysms

Stroke is the leading cause of disability among adults and one of the three leading causes of death in North America.


Grant type
Team grants
Area of Research
Injury
Competition
Heart and Stroke Foundation Grant-in-Aid
Province
Newfoundland and Labrador
Start Date
2015

Mitochondrial calcium uptake and targeted therapeutics

Stroke is the sudden death of brain cells caused by insufficient blood supply to the brain. Parts of the brain that enable us to walk and talk are often damaged most by a stroke.


Grant type
Team grants
Area of Research
Injury
Competition
Heart and Stroke Foundation Grant-in-Aid
Province
Nova Scotia
Start Date
2015

Mechanisms of delayed death in stroke

Stroke is a major cause of death and disability. At present, there are no clear and effective therapies to aid the majority of patients who suffer stroke.


Grant type
Team grants
Area of Research
Injury
Competition
Heart and Stroke Foundation Grant-in-Aid
Province
Ontario
Start Date
2015

Role of ATF4 and P53 family transcription factors in the regulation of neuronal cell death

Stroke is a leading cause of adult long term disability and the third leading cause of death in industrialized countries.


Grant type
Team grants
Area of Research
Injury
Competition
Heart and Stroke Foundation Grant-in-Aid
Province
Ontario
Start Date
2015

Investigation of the innate immune system and motor neuron degeneration in genetic models of ALS

In recent years, it was discovered that a microscopic worm called C. elegans could mimic some of the aspects of human ALS when they were engineered to have abnormal (mutant) genes that cause the disease.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Discovery Grants
Province
Québec
Start Date
2015

Characterizing the C9ORF72 protein interactome for identifying novel pathogenic pathways in ALS

In late 2011, a landmark discovery was made which identified that abnormalities (mutation) in a gene called C9ORF72 were responsible for the highest percentage of hereditary ALS and frontotemporal dementia cases.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Discovery Grants
Province
Ontario
Start Date
2015

Synaptic inhibition in the motor cortex of an ALS mouse model

ALS is a disease characterized by degeneration of both upper and lower motor neurons.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Discovery Grants
Province
Ontario
Start Date
2015

Study of the impact of glycation on ALS using an in vitro tissue-engineered model of spinal cord

Tissue engineering is a process that was originally designed and continues to be used for growing cells outside the body, turning them into functional tissues and organs, and applying them for clinical use.


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Canada - Brain Canada Discovery Grants
Province
Québec
Start Date
2015

Preclinical and clinical studies with withanolides: Therapeutic effects, molecular signatures and biomarkers

One of the hallmarks of ALS is the presence of abnormal clumps inside motor neurons that contain various substances which include, in the majority of cases, something called TAR DNAbinding protein 43 (TDP-43).


Grant type
Team grants
Area of Research
Neurodegeneration
Competition
ALS Arthur J. Hudson Translational Team Grant
Province
Québec
Start Date
2015